![Hyperkalaemia - Japan’s Ministry of Health, Labour and Welfare has approved AstraZeneca’s Lokelma](https://news.europawire.eu/wp-content/uploads/2020/03/Hyperkalaemia-Japan’s-Ministry-of-Health-Labour-and-Welfare-has-approved-AstraZeneca’s-Lokelma-144x144.png)
(PRESS RELEASE) CAMBRIDGE, 26-Mar-2020 — /EuropaWire/ — Science-led biopharmaceutical group AstraZeneca (LSE/STO/NYSE: AZN) has announced that its Lokelma (sodium zirconium cyclosilicate) is now approved in Japan. It is used for the treatment of patients with hyperkalaemia (elevated levels of potassium … Read the full press release